Skip to content

A Clinical Trial to Study the Effect of Triphala in A Patients with Arthritis

Effect of Triphala (Polyherbal Formulation) in the Management of Arthritis - A Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/045098
Enrollment
54
Registered
2022-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Sponsors

KLE Academy of higher education and research Belagavi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male and female Patients with age between 40-70 years

Exclusion criteria

Exclusion criteria: � Patients having severe OA � Pregnant and lactating women � Any other conditions which in the opinion of investigator will place the subject at risk or will influence the conduct of study or interpretation of results

Design outcomes

Primary

MeasureTime frame
Triphala (Polyherbal formulation) if proved more efficacious would help in treating arthritis more efficiently. Parameters at screening: Subjective parameters: Pain (VAS), Tenderness, Redness (Raga), Shotha (Swelling/Inflammation), Stabdata (Stiffness), Physician Global Assessment WOMAC Scale Objective parameters: Range of Motion (Goniometer) Timepoint: 90 days of therapy. Follow up on 30th , 60th , and 90th day after treatment period.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Sunil Jalalpure

KLE College of Pharmacy, Belagavi

jalalpuresunil@rediffmail.com9448964057

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026